Biocon CTO Ghatnekar to step down; Mukesh Rathi appointed

Key managerial personnel resignedManagement Changes View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹343.30

prior close

₹348.05

announcement price

In-mkt

timing

Nifty Midcap 150market+1.6%-1.5% vs market

Pharmaceuticals peers, median of 173sector+0.8%-0.7% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Midcap 150 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-0.9

15m

-0.9

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1+1.6-1.5+0.8-0.7

Next day

+5.5pendingpending+1.6+3.9

+6.4pendingpending+1.5+4.9

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon's board noted Dr. Mandar Shrikant Ghatnekar's resignation as Chief Technology Officer and senior management, effective close of business on December 31, 2026, to pursue opportunities outside the company. Mukesh Rathi will take over on January 1, 2027. He has over 27 years of experience in digital transformation, technology management and AI-led innovation.

Likely market impact

There is no leadership gap because Rathi takes over the next day. Shareholders should watch execution after the January transition.